CaRi-heart technology
Revolutionary new technology to assess the risk of a serious heart condition or heart attack – many years before anything happens.
Myeloma causes abnormal plasma cells (a type of white blood cell) to overcrowd the bone marrow. This means there is not enough space for the bone marrow to create normal blood cells and platelets.
These plasma cells can also cause damage to the bones, causing bone thinning and fractures.
The excess protein secreted by the abnormal cells can significantly affect kidney function.
Symptoms of myeloma may include:
Myeloma cells also cause bone damage, which can lead to bone pain and fractures. These symptoms can often be related to a number of non-cancerous conditions. However, if you experience any of these symptoms, it is important to see your GP so that a referral and diagnosis can be made as quickly as possible.
We offer a number of investigations or tests to confirm a diagnosis of myeloma, including:
At HCA UK you will be looked after by a multidisciplinary team, including expert consultants, Clinical Nurse Specialists (CNSs) and supportive therapists such as psychologists who can help you with your emotional wellbeing. We understand the importance of a fast diagnosis during such an uncertain time. We’re dedicated to having test results available as quickly as possible, so you can begin any necessary treatment without delay.
Because there are different types and stages of myeloma, each treatment plan is tailored to you. Your consultant and medical team will discuss your diagnosis with you in detail and explain the different types of treatment available.
Options may include:
Currently there is no cure for the vast majority of patients with myeloma, but treatment can help to slow the development of myeloma cells and improve your symptoms. We also provide a range of supportive therapies, including physio and acupuncture, to help support your overall wellbeing during your treatment.
After visiting his GP about a 'barely noticeable' lump on the side of his neck which was found to be benign, Solomon, who felt otherwise fit and well, was shocked to be diagnosed with a rare type of blood cancer – multiple myeloma – in 2018.
In 2010 Vanessa was diagnosed with myeloma - an incurable type of blood cancer - after seeking medical help for severe back pain, which she initially assumed was an injury from climbing; a hobby she had taken up earlier in the year. This year, Vanessa was amongst the first patients in the UK to be treated with the latest breakthrough treatment – Teclistamab; a type of immunotherapy known as a bispecific antibody.
Amyloidosis is a non cancerous condition that can be related to myeloma. Amyloidosis is a group of rare diseases that cause abnormal protein (amyloid) to form. These amyloid proteins (or amyloid deposits) can build up in organs or tissues and cause problems. Amyloidosis itself is not by definition malignant but some can be connected to myeloma.
There are different types of amyloidosis, your consultant and medical team will discuss your diagnosis with you in detail and explain the different types of treatment available to you.
At HCA UK we work with world-renowned consultant specialists who are experts in treating this rare condition.
This content is intended for general information only and does not replace the need for personal advice from a qualified health professional.